Cargando…
Pharmacogenetics implementation in the clinics: information and guidelines for germline variants
The aim of this work was to supply an overview of the germline Pharmacogenetics that can be already implemented in the oncology clinical practice. An explanation of the three pillars considered necessary for determining which genetic polymorphisms should be used has been provided. These are PharmGKB...
Autores principales: | Olivera, Gladys, Sendra, Luis, Herrero, María José, Berlanga, Pablo, Gargallo, Pablo, Yáñez, Yania, Urtasun, Andrea, de Mora, Jaime Font, Castel, Victoria, Cañete, Adela, Aliño, Salvador F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
OAE Publishing Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019171/ https://www.ncbi.nlm.nih.gov/pubmed/35582138 http://dx.doi.org/10.20517/cdr.2018.25 |
Ejemplares similares
-
Pharmacogenetics in Neuroblastoma: What Can Already Be Clinically Implemented and What Is Coming Next?
por: Olivera, Gladys G., et al.
Publicado: (2021) -
MTHFR and VDR Polymorphisms Improve the Prognostic Value of MYCN Status on Overall Survival in Neuroblastoma Patients
por: Olivera, Gladys G., et al.
Publicado: (2020) -
Personalized Medicine in Infant Population with Cancer: Pharmacogenetic Pilot Study of Polymorphisms Related to Toxicity and Response to Chemotherapy
por: Urtasun, Andrea, et al.
Publicado: (2023) -
Next-Generation Sequencing Identifies Potential Actionable Targets in Paediatric Sarcomas
por: Juan Ribelles, Antonio, et al.
Publicado: (2021) -
Germline Predisposition to Pediatric Cancer, from Next Generation Sequencing to Medical Care
por: Gargallo, Pablo, et al.
Publicado: (2021)